Literature DB >> 20231628

Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations.

Wen T Shen1, Lauren Ogawa, Daniel Ruan, Insoo Suh, Electron Kebebew, Quan-Yang Duh, Orlo H Clark.   

Abstract

BACKGROUND: The American Thyroid Association recently changed its management guidelines for papillary thyroid cancer (PTC) to include routine central neck lymph node dissection (CLND) during thyroidectomy. We currently perform CLND during thyroidectomy only if enlarged central nodes are detected by palpation or ultrasonography; we perform CLND in the reoperative setting for recurrence in previously normal-appearing or incompletely resected nodes. Critics of this approach argue that reoperative CLND has higher complication and recurrence rates than initial CLND. We sought to test this argument, using it as our hypothesis.
DESIGN: Retrospective review.
SETTING: University hospital. PATIENTS: All patients undergoing CLND for PTC between January 1, 1998, and December 31, 2007.
INTERVENTIONS: Thyroidectomy and CLND. MAIN OUTCOME MEASURES: Complications (neck hematoma, recurrent laryngeal nerve injury, and hypoparathyroidism) and recurrence of PTC.
RESULTS: Altogether, 295 CLNDs were performed: 189 were initial operations and 106 were reoperations. The rate of transient hypocalcemia (41.8% vs 23.6%) was significantly higher in patients undergoing initial CLND compared with those undergoing reoperative CLND. Rates of neck hematoma (1.1% vs 0.9%), transient hoarseness (4.8% vs 4.7%), permanent hoarseness (2.6% vs 1.9%), and permanent hypoparathyroidism (0.5% vs 0.9%) were not different between initial and reoperative CLND. In addition, recurrence rates in the central (11.6% vs 14.1%) and lateral (21.7% vs 17.0%) compartments were not different between the 2 groups.
CONCLUSIONS: Reoperative CLND for PTC has a lower rate of temporary hypocalcemia, the same rate of other complications, and the same rate of recurrence compared with initial CLND. Choosing to observe nonenlarged central neck lymph nodes for PTC does not result in increased complications or recurrence if reoperation is required.

Entities:  

Mesh:

Year:  2010        PMID: 20231628     DOI: 10.1001/archsurg.2010.9

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  30 in total

Review 1.  Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection.

Authors:  Robin M Cisco; Wen T Shen; Jessica E Gosnell
Journal:  Curr Treat Options Oncol       Date:  2012-03

Review 2.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

3.  Central compartment neck dissection for thyroid cancer: a surgical technique.

Authors:  Dana M Hartl; Jean-Paul Travagli
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

4.  Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.

Authors:  Gabriele Molteni; Marco Bonali; Francesco Mattioli; Michael Ghirelli; Matteo Fermi; Gaetano Ferri; Malagoli Andrea; Livio Presutti
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-10       Impact factor: 2.503

5.  Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence.

Authors:  Pietro Giorgio Calò; Celestino Pio Lombardi; Francesco Podda; Luca Sessa; Luigi Santini; Giovanni Conzo
Journal:  Updates Surg       Date:  2017-04-13

6.  Radioguided occult lesion localization in patients with recurrent thyroid cancer.

Authors:  Murat Tuncel; Nilda Süslü
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-18       Impact factor: 2.503

7.  Long-term results of surgery for papillary thyroid carcinoma with local recurrence.

Authors:  Hiroki Uchida; Tsuneo Imai; Toyone Kikumori; Hironori Hayashi; Shigenori Sato; Sumiyo Noda; Ai Idota; Tetsuya Kiuchi
Journal:  Surg Today       Date:  2012-10-10       Impact factor: 2.549

8.  Morbidity of central neck dissection: primary surgery vs reoperation. Results of a case-control study.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Carmela De Crea; Luca Sessa; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

9.  Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; George C C Lee; Cathy P C Ng; Kai Pun Wong; Koon Yat Wan; Chung-Yau Lo
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

10.  Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.